Fibrinogen Gamma Chain AGDV Peptide
€137.00
In stock
SKU
350038
Protein Family: CAM Ligands
Pathway and Disease: Cancers
Alternate Names: Fibrinogen gamma chain; FGG
Accession No.: P02679
Description:
The AGDV peptide corresponds to the C-term end of fibrinogen gamma chain responsible of platelet aggregation.
Format:
Each vial contains 5 mg of lyophilized solid packaged under an inert gas and supplied as a trifluoroacetate salt.
MW: 360.37 g/mol
Sequence:
Human: H-Ala-Gly-Asp-Val-OH or H-AGDV-OH
Composition:
C14H24N4O7
Purity:
> 95% by HPLC
Solubility:
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Storage:
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, aliquot and store at -20°C.
Pathway and Disease: Cancers
Alternate Names: Fibrinogen gamma chain; FGG
Accession No.: P02679
Description:
The AGDV peptide corresponds to the C-term end of fibrinogen gamma chain responsible of platelet aggregation.
Format:
Each vial contains 5 mg of lyophilized solid packaged under an inert gas and supplied as a trifluoroacetate salt.
MW: 360.37 g/mol
Sequence:
Human: H-Ala-Gly-Asp-Val-OH or H-AGDV-OH
Composition:
C14H24N4O7
Purity:
> 95% by HPLC
Solubility:
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Storage:
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, aliquot and store at -20°C.
| Is Featured? | No |
|---|
Write Your Own Review